The One Big Beautiful Bill Act, also known as H.R. 1, will block refugees and asylees from Medicare and Medicaid, among other restrictions ...
PBMs typically receive a portion of rebates paid by drug manufacturers, the majority of which are passed back to the payer as an incentive to prefer a drug on a formulary. PBMs may also retain revenue ...
On telehealth, value-based care, diabetes prevention, doctor burnout and more, members of Congress have worked to find common ground.
Your Social Security benefits may be safe from creditors, but not from the federal government.
The legislation will impose new restrictions on pharmacy benefit managers, giant companies like CVS Caremark, Optum Rx and ...
Novo Noranisisk A/S shocked investors by forecasting a steep decline in sales this year, a sign of how intensifying price wars in obesity drugs and the Trump administration’s pressure on ...
After Republicans let enhanced premium tax credits for Affordable Care Act Marketplace plans lapse at the end of 2025, health insurance premium costs for many Americans have risen significantly — and ...
Total net revenue of $15.2 million Adjusted EBITDA1 of $ (0.8) million, which includes EXXUA launch investments $30.0 million cash balance at December 31, 2025 Company launched EXXUA™ (gepirone) ...
Total net revenue of $15.2 millionAdjusted EBITDA1 of $(0.8) million, which includes EXXUA launch investments$30.0 million cash balance at December 31, 2025Company launched EXXUA (gepirone) extended-r ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results